Search - tctmd.com

Displaying 1 - 20 of 229

Sort: Relevancy | Date

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

December 31, 2025

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

October 27, 2025

What’s Going to Be Hot at TCT 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

August 13, 2025

Money Talk: Cardiologists Must Weigh Costs as Transcatheter Therapies Ascend

News Daily News

Money Talk: Cardiologists Must Weigh Costs as Transcatheter Therapies Ascend

August 11, 2025

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

July 31, 2025

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

July 30, 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

News Conference News NY Valves 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

June 30, 2025

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

News Conference News NY Valves 2025

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Yael L. Maxwell

June 30, 2025

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

News Daily News

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Michael O'Riordan

May 28, 2025

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

February 21, 2025

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

February 14, 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

News Conference News STS 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Yael L. Maxwell

February 05, 2025

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

News Conference News PCR London Valves 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.